Skip to Content

Cefotan Dosage

Generic name: Cefotetan Disodium 1g in 10mL
Dosage form: injection, powder, for solution

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Treatment

The usual adult dosage is 1 or 2 grams of CEFOTAN® (cefotetan for Injection, USP) administered intravenously or intramuscularly.  Proper dosage and route of administration should be determined by the condition of the patient, severity of the infection, and susceptibility of the causative organism.

                 General Guidelines for Dosage of CEFOTAN® (cefotetan for Injection, USP)

Type of Infection

Daily Dose

Frequency and Route

Urinary Tract



1 to 4 grams

500 mg every 12 hours IV or IM

1 or 2 g every 24 hours IV or IM

1 or 2 g every 12 hours IV or IM


   

Skin & Skin Structure



   Mild - Moderatea




    Severe


2 grams

2 g every 24 hours IV

1 g every 12 hours IV or IM


 4 grams
 2 g every 12 hours IV

Other Sites

2 to 4 grams

1 or 2 g every 12 hours IV or IM

Severe

4 grams

2 g every 12 hours IV

Life-Threatening

6 gramsb

3 g every 12 hours IV

aKlebsiella pneumoniae skin and skin structure infections should be treated with 1 or 2 grams every 12 hours IV or IM.

b Maximum daily dosage should not exceed 6 grams.

If Chlamydia trachomatis is a suspected pathogen in gynecologic infections, appropriate antichlamydial coverage should be added, since cefotetan has no activity against this organism.

Prophylaxis

To prevent postoperative infection in clean contaminated or potentially contaminated surgery in adults, the recommended dosage is 1 or 2 g of CEFOTAN® (cefotetan for Injection, USP) administered once, intravenously, 30 to 60 minutes prior to surgery.  In patients undergoing cesarean section, the dose should be administered as soon as the umbilical cord is clamped.

Impaired Renal Function

When renal function is impaired, a reduced dosage schedule must be employed.  The following dosage guidelines may be used.

DOSAGE GUIDELINES FOR PATIENTS WITH IMPAIRED RENAL FUNCTION

Creatinine Clearance

mL/min

 

Dose

 

Frequency

> 30

Usual Recommended Dosage*

Every 12 hours

10 to 30

Usual Recommended Dosage*

Every 24 hours

< 10

Usual Recommended Dosage*

Every 48 hours

* Dose determined by the type and severity of infection, and susceptibility of the causative organism.

Alternatively, the dosing interval may remain constant at 12 hour intervals, but the dose reduced to one-half the usual recommended dose for patients with a creatinine clearance of 10 to 30 mL/min, and one-quarter the usual recommended dose for patients with a creatinine clearance of less than 10 mL/min.

When only serum creatinine levels are available, creatinine clearance may be calculated from the following formula.  The serum creatinine level should represent a steady state of renal function.


Males:                 Weight (kg) x (140 - age)                

                      72 x serum creatinine (mg/100 mL)


Females:   0.85 x value for males


Cefotetan is dialyzable and it is recommended that for patients undergoing intermittent hemodialysis, one-quarter of the usual recommended dose be given every 24 hours on days between dialysis and one-half the usual recommended dose on the day of dialysis.

Preparation of Solution

For Intravenous Use

Reconstitute with Sterile Water for Injection.  Shake to dissolve and let stand until clear.



Vial Size

Amount of

Diluent

Added (mL)

Approximate Withdrawable

Vol (mL)

Approximate

Average Concentration (mg/mL)

1 gram

10

10.5

95

2 gram

10 to 20

11 to 21

182 to 95

For Intramuscular Use

Reconstitute with Sterile Water for Injection; Bacteriostatic Water for Injection; Sodium Chloride Injection 0.9%, USP; 0.5% Lidocaine HCl; or 1% Lidocaine HCl.  Shake to dissolve and let stand until clear.



Vial Size

Amount of

Diluent

Added (mL)

Approximate Withdrawable

Vol (mL)

Approximate

Average Concentration

(mg/mL)

1 gram

2

2.5

400

2 gram

3

4

500

Intravenous Administration

The intravenous route is preferable for patients with bacteremia, bacterial septicemia, or other severe or life-threatening infections, or for patients who may be poor risks because of lowered resistance resulting from such debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure, or malignancy, particularly if shock is present or impending.

For intermittent intravenous administration, a solution containing 1 gram or 2 grams of CEFOTAN® (cefotetan for Injection, USP) in Sterile Water for Injection can be injected over a period of three to five minutes. Using an infusion system, the solution may also be given over a longer period of time through the tubing system by which the patient may be receiving other intravenous solutions.  Butterfly® or scalp vein-type needles are preferred for this type of infusion.  However, during infusion of the solution containing CEFOTAN® (cefotetan for Injection, USP), it is advisable to discontinue temporarily the administration of other solutions at the same site.

NOTE: Solutions of cefotetan must not be admixed with solutions containing aminoglycosides.  If CEFOTAN® and aminoglycosides are to be administered to the same patient, they must be administered separately and not as a mixed injection.

Intramuscular Administration

As with all intramuscular preparations, CEFOTAN® (cefotetan for Injection, USP) should be injected well within the body of a relatively large muscle such as the upper outer quadrant of the buttock (i.e., gluteus maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel.

Compatibility and Stability

Frozen samples should be thawed at room temperature before use.  After the periods mentioned below, any unused solutions or frozen material should be discarded.  DO NOT REFREEZE.

NOTE: Solutions of CEFOTAN® (cefotetan for Injection, USP) must not be admixed with solutions containing aminoglycosides.  If CEFOTAN® (cefotetan for Injection, USP) and aminoglycosides are to be administered to the same patient, they must be administered separately and not as a mixed injection.  DO NOT ADD SUPPLEMENTARY MEDICATION.

CEFOTAN® (cefotetan for Injection, USP) reconstituted as described above (see DOSAGE AND ADMINISTRATION,Preparation of Solution) maintains satisfactory potency for 24 hours at room temperature (25ºC/77ºF), for 96 hours under refrigeration (5ºC/41ºF), and for at least 1 week in the frozen state (-20ºC/-4ºF).  After reconstitution and subsequent storage in disposable glass or plastic syringes, CEFOTAN® (cefotetan for Injection, USP) is stable for 24 hours at room temperature and 96 hours under refrigeration.

NOTE: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Hide